Mobile Health Network Solutions Reports 1H Financials
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 12 2026
0mins
Should l Buy MNDR?
Source: seekingalpha
- Revenue Performance: Mobile Health Network Solutions reported $3.98 million in revenue for the first half of 2023, indicating growth but still falling short of profitability, highlighting challenges in market competition.
- Gross Profit: The company achieved a gross profit of $795,303 during the same period, with a relatively low gross margin that reflects pressure on profitability due to high operating costs.
- Net Loss: The net loss for the reporting period was $858,417, indicating significant challenges in cost control and revenue enhancement, which may impact future financing capabilities and investor confidence.
- Cash Flow Status: As of the end of the reporting period, the company had cash and cash equivalents of $3.48 million, providing some liquidity, but ongoing losses raise concerns about the potential impact on cash flow sustainability.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MNDR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MNDR
About MNDR
Mobile-Health Network Solutions is a telehealth solutions provider in Singapore. The Company provides its services on its MaNaDr platform, which is a 360-degree healthcare ecosystem which connects users and service providers through a range of healthcare services and product offerings that can be accessed through its mobile application and Website. Through its mobile application, it offers users seamless and hassle-free telehealth solutions, which encompass teleconsultation services, including the issuance of electronic medical certificates and delivery of medications to users’ homes and other personalized services. Its segments are telemedicine and other services and the sale of medicine and medical devices. The platform encompasses various components: MaNaDr Mobile Application; MaNaDr Clinic; MaNaPharma; MaNaShop/MaNaStore and MaNaCare. It offers a diversified range of products to users on the MaNaShop/MaNaStore online e-commerce platform, including healthcare products.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Acquisition Overview: The Singaporean AI HealthTech platform is acquiring PPG through a Cayman Islands SPV for $1.5 million, primarily to hold a stake in IRIX Properties, which will build a 25 MW AI data center in Malaysia.
- Equity Structure and Investment: PPG will hold at least a 96.5% stake in IRIX Properties, while PPG's shareholder, Dato' Ling Tiung Leng, is expected to inject approximately $127 million for data center construction in exchange for a 65% equity stake in MNDR.
- Market Reaction and Stock Volatility: Following the acquisition announcement, shares of Mobile-health Network Solutions (MNDR) surged over 24% on Friday, despite a nearly 90% decline over the past year, indicating a positive market response to the deal.
- Future Financing Plans: MNDR plans to independently raise at least $100 million to support future expansion and ultimately aims to list the Cayman SPV on a recognized exchange to fund ongoing AI data center development.
See More

Company Overview: Mobile Health Network Solutions is a company focused on providing healthcare solutions through mobile technology.
Investment Structure: PPG will serve as a primary holding vehicle with a minimum equity interest of 96.5% in the investment.
Property Management: The investment involves managing properties under the name Irix Properties SDN. BHD.
Strategic Goals: The company aims to leverage its equity interest to enhance its operational capabilities and market presence in the healthcare sector.
See More

- Acquisition Announcement: Mobile Health Network Solutions will acquire PP&G, enhancing their service offerings in the healthcare sector.
- Special Purpose Vehicle: The acquisition will be facilitated through a special purpose vehicle based in the Cayman Islands.
See More

- Acquisition Announcement: Mobile Health Network Solutions has entered into a definitive agreement to acquire PPG and Kuching Data Center assets.
- Strategic Expansion: This acquisition aims to enhance Mobile Health Network Solutions' capabilities and expand its service offerings in the healthcare sector.
See More
- Revenue Performance: Mobile Health Network Solutions reported $3.98 million in revenue for the first half of 2023, indicating growth but still falling short of profitability, highlighting challenges in market competition.
- Gross Profit: The company achieved a gross profit of $795,303 during the same period, with a relatively low gross margin that reflects pressure on profitability due to high operating costs.
- Net Loss: The net loss for the reporting period was $858,417, indicating significant challenges in cost control and revenue enhancement, which may impact future financing capabilities and investor confidence.
- Cash Flow Status: As of the end of the reporting period, the company had cash and cash equivalents of $3.48 million, providing some liquidity, but ongoing losses raise concerns about the potential impact on cash flow sustainability.
See More
- Earnings Surprise: Pitney Bowes reported an adjusted EPS of 45 cents for Q4, surpassing the analyst consensus of 38 cents, indicating strong profitability and boosting investor confidence.
- Sales Miss: The quarterly sales of $478 million fell short of the expected $486.68 million, highlighting some market demand challenges that could impact future revenue growth.
- Stock Surge: The company's shares jumped 7.9% to $11.05 in pre-market trading, reflecting optimistic market sentiment regarding its future prospects and potentially attracting more investor interest.
- Positive Guidance: Pitney Bowes issued FY26 adjusted EPS guidance with a midpoint above estimates, further strengthening market confidence in its long-term growth potential.
See More






